Scinai Immunotherapeutics Ltd. (TLV:BVXV)
49.30
-1.00 (-1.99%)
At close: Jan 18, 2018
Scinai Immunotherapeutics Employees
Scinai Immunotherapeutics had 31 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
31
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
134.82K ILS
Profits / Employee
-854.28K ILS
Market Cap
6.20M
Employees Chart
Related Stocks
Employee RankingsScinai Immunotherapeutics News
- 4 days ago - Why Scinai Immunotherapeutics Stock Is Skyrocketing 90% Higher Today - Benzinga
- 4 days ago - Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing - PRNewsWire
- 22 days ago - Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities - PRNewsWire
- 27 days ago - Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration - PRNewsWire
- 5 weeks ago - Scinai Immunotherapeutics Highlights Expanded CDMO Platform and Immunology Pipeline at BIO-Europe Spring® 2026 - PRNewsWire
- 6 weeks ago - Scinai Immunotherapeutics Receives Nasdaq Notification Regarding Minimum Bid Price - PRNewsWire
- 2 months ago - Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised €12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept - PRNewsWire
- 2 months ago - Scinai Announces Expanded Israel Innovation Authority Support for Robotic Aseptic Fill & Finish Platform - PRNewsWire